Pharmacokinetic evaluation of cefoperazone in infants.
AUTOR(ES)
Varghese, M
RESUMO
The pharmacokinetics of cefoperazone were evaluated in 25 infants (mean age, 26 days) after intramuscular and intravenous routes of administration. The levels in blood that were achieved were severalfold higher than those required to inhibit common pathogens. The mean half-life of 240 min was one-half of that observed in 1- to 2-day-old infants but about twice that seen in adults. Further evaluation is needed to study the efficacy of the drug in infants and children.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=176329Documentos Relacionados
- Cefoperazone pharmacokinetics in preterm infants.
- Pharmacokinetic properties of mezlocillin in newborn infants.
- Clinical and pharmacokinetic evaluation of parenteral moxalactam in infants and children.
- Clinical and Pharmacokinetic Evaluation of Parenteral Cefoxitin in Infants and Children
- Ranitidine in infants.
